Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2011-03-01
2011-03-01
Wang, Shengjun (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
active
07897645
ABSTRACT:
A therapeutic agent for treatment of herpes virus-derived pain which comprises (±)-[2-[4-(3-ethoxy-2-hydroxy-propoxy) phenylcarbamoyl]ethyl]dimethylsulfonium p-toluenesulfonate represented by the formula (1) as an active ingredient.
REFERENCES:
patent: 4556737 (1985-12-01), Koda et al.
patent: 6329428 (2001-12-01), Yamauchi et al.
patent: 2003/0149105 (2003-08-01), Ushio et al.
patent: 11-315019 (1999-11-01), None
patent: 2002-114672 (2002-04-01), None
patent: 2004-292407 (2004-10-01), None
patent: WO 0154652 (2001-08-01), None
Tamaoki et al. “Effect of suplatast tosilat, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind reandomised study,” The Lancet, 2000, vol. 356, pp. 273-278.
Katakura et al. “Effect of IL-12 and soluble IL-4 receptor on the herpesvirus infection in human SCID chimeras whose Th2 cells predominate,” Immunology and Cell Biology, 2004, vol. 82, pp. 421-426.
Higa, Kazuo, et al., “Postherpetic neuralgia: diagnosis and treatment”,Pain Clinic, vol. 25, No. 2, 2004 pp. 158-165.
Miura, Masanao, “Taijohoshintsu to Taijohoshingo Shinkeitsu”The Journal of Therapy, 2003, vol. 85, No. 7, pp. 2097-2104.
Yoshimura, Naoki, et al., “Targeting Afferent Hyperexcitability for Therapy of the Painful Bladder Syndrome”,Urology, 2002, vol. 59. No. 5 Suppl., 1, pp. 61-67.
Yokota, Toshikatsu, “Mechanism of chronic pain”,Pain Clinicvol. 22, No. 4, 2001 pp. 505-510.
Hira Kayako
Kiniwa Mamoru
Ogawa Hideoki
Juntendo Educational Foundation
Kubovcik & Kubovcik
Taiho Pharmaceutical Co. Ltd.
Wang Shengjun
LandOfFree
Herpesvirus-derived therapeutic agent for pain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Herpesvirus-derived therapeutic agent for pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Herpesvirus-derived therapeutic agent for pain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2695917